Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor
Reexamination Certificate
2005-11-29
2010-11-09
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Bacteria or actinomycetales; media therefor
C435S071100, C435S071300, C435S243000, C435S253600, C424S240100, C530S350000
Reexamination Certificate
active
07829321
ABSTRACT:
Methods and compositions are provided for the enhanced production of bacterial toxins in large-scale cultures. Specifically, methods and compositions for reducing bacterial toxin expression inhibitors are providing including, but not limited to, addition of toxin expression inhibitor binding compounds, culture media having reduced concentrations of toxin inhibitor metabolic precursors and genetically modified toxogenic bacteria lacking enzymes required to metabolize the toxin inhibitor metabolic precursors.
REFERENCES:
patent: 4950599 (1990-08-01), Bertling
patent: 4965205 (1990-10-01), Quentin-Millet et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5338670 (1994-08-01), Sekura et al.
patent: 5460941 (1995-10-01), Camerini-Otero et al.
patent: 5557032 (1996-09-01), Mak
patent: 5612205 (1997-03-01), Kay et al.
patent: 5614396 (1997-03-01), Bradley et al.
patent: 5616491 (1997-04-01), Mak et al.
patent: 5703038 (1997-12-01), Ammons et al.
patent: 5777195 (1998-07-01), Fienberg et al.
patent: 5789215 (1998-08-01), Berns et al.
patent: 5830761 (1998-11-01), Drapeau et al.
patent: 5948653 (1999-09-01), Pati et al.
patent: 5965443 (1999-10-01), Reznikoff et al.
patent: 6015676 (2000-01-01), Lin et al.
patent: 6031149 (2000-02-01), Chambon et al.
patent: 6686180 (2004-02-01), Blake et al.
patent: 7018813 (2006-03-01), Blake et al.
patent: 7045314 (2006-05-01), Blake et al.
Sekura et al., “Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase,” Journal of Biological Chemsitry, vol. 258, No. 23, pp. 14647-14651 (Dec. 1983).
Andresen, FEMS Immunology and Medical Microbiology 23: 295-301 (1999).
Bogdan et al., Infection and Immunity 69(11): 6823-6830 (2001).
Frohlich et al., Journal of Biotechnology 39: 205-219 (1995).
Karlsson et al., Infection and Immunity 68(10); 5881-5888 (2000).
Lisker et al., Canadian Journal of Microbiology 31(11): 973-976 (1985).
Stenson et al., Infection and Immunity 71(3): 1316-1320 (2003).
Blake et al., Patent App. Publication No. US 2005/0100553 (U.S. Appl. No. 10/677,496) (May 12, 2005).
Blake et al., Patent App. Publication No. US 2002/0165344 (U.S. Appl. No. 09/825,769) (Nov. 17, 2002).
Mihara et al., Journal of Biological Chemistry 272(36): 22417-22424, Sep. 1997.
Blake et al., Pub. No. US 2006/0216789 (U.S. Appl. No. 11/262,836).
Hofreuter et al., Mol Microbiol. 28(5): 1027-1038 (1998) (Abstract).
Zhou et al., J Tongji Med Univ. 20(4): 273-276 (2000), Abstract only.
Mosqueda et al., J Bacteriol. 182(4): 937-943 (2000), Abstract only.
Blake Milan S.
Bogdan, Jr. John A.
Nazario-Larrieu Javier
Baxter Healthcare S.A.
Baxter International Inc.
Lucas Zachariah
Perkins Coie LLP
LandOfFree
Method for the production of bacterial toxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the production of bacterial toxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the production of bacterial toxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4190950